Codexis (CDXS) EBITDA Margin (QoQ) (2010 - 2026)
Codexis (CDXS) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,988.00 |
| Dec 31, 2025 | 24,745.00 |
| Sep 30, 2025 | -13,640.00 |
| Jun 30, 2025 | 18,768.00 |
| Mar 31, 2025 | -23,738.00 |
| Dec 31, 2024 | 9,481.00 |
| Sep 30, 2024 | 15,588.00 |
| Jun 30, 2024 | -21,527.00 |
| Mar 31, 2024 | -7,525.00 |
| Dec 31, 2023 | 35,121.00 |
| Sep 30, 2023 | -9,307.00 |
| Jun 30, 2023 | -7,023.00 |
| Mar 31, 2023 | -11,537.00 |
| Dec 31, 2022 | -3,606.00 |
| Sep 30, 2022 | -2,406.00 |
| Jun 30, 2022 | 1,694.00 |
| Mar 31, 2022 | 1,866.00 |
| Dec 31, 2021 | -4,600.00 |
| Sep 30, 2021 | 2,124.00 |
| Jun 30, 2021 | 3,315.00 |